Autologous cord blood vs individualized supplements in autistic spectrum disorder: CORDUS study results

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 1

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Pediatrics

ISSN

2219-2808

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Clin Pediatr. Mar 9, 2025; 14(1): 96643
Published online Mar 9, 2025. doi: 10.5409/wjcp.v14.i1.96643

Full Size Figure Download Figure

Figure 1 CORDUS study design.

Citation: Stancioiu FA, Bogdan R, Ivanescu B, Dumitrescu R. Autologous cord blood vs individualized supplements in autistic spectrum disorder: CORDUS study results. World J Clin Pediatr 2025; 14(1): 96643
URL: https://www.wjgnet.com/2219-2808/full/v14/i1/96643.htm
DOI: https://dx.doi.org/10.5409/wjcp.v14.i1.96643

Stancioiu FA, Bogdan R, Ivanescu B, Dumitrescu R. Autologous cord blood vs individualized supplements in autistic spectrum disorder: CORDUS study results. World J Clin Pediatr 2025; 14(1): 96643 [PMID: 40059901 DOI: 10.5409/wjcp.v14.i1.96643]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.